David Evendon-Challis

Experience

• 

  Kimberly-Clark

  Jan 2002 - Jan 2006

  Regional Manager

  Regional manager for Kimberly-Clark, responsible for EHS issues in Europe.Auditing to ISO 14001, crisis and issue management, proactive environmental objectives setting at a corporate and facility level, regulatory affairs.

• 

  Kimberly-Clark

  Feb 2006 - Sept 2009

  Head of Sustainability & Public Affairs EMEA

  As Head of Sustainability & Public Affairs EMEA, I was responsible for corporate and product sustainability strategy and implementation, as well as public affairs, for the Europe, Middle East and Africa Region. This included corporate, business unit and brand strategy and internal engagement as well as external relations - including NGO management, trade association management, conference speaking and issues management.Kimberly-Clark is a leading global company employing 53,000 people worldwide and posting sales of US$19.4 billion in 2008. Headquartered in Dallas, Texas, with operations in 37 countries, Kimberly-Clark’s global brands are sold in more than 150 countries. Every day, 1.3 billion people trust Kimberly-Clark's essential products and the solutions they provide to make their lives better. With well-known core brands such as KLEENEX®, SCOTT®, ANDREX®, HUGGIES®, PULL-UPS®, KOTEX®, POISE® AND DEPEND®, we hold the No. 1 or No. 2 share position globally in more than 80 countries. Globally, medical professionals turn to Kimberly-Clark Health Care for a wide portfolio of solutions essential to the health and hygiene of their patients and staff. Even when they're not at home, people all around the world use Kimberly-Clark Professional's washroom, workplace, safety and do-it-yourself solutions. Weniger anzeigen

• 

  MHP Communications

  Aug 2009 - Jan 2011

  Associate Director

  As Associate Director of the sustainabiltiy practice within MHP (formerly Mandate) Communications, I lead strategy and communications initiatives for large consumer-facing and B2B businesses, as well as for NGOs and standards groups.MHP is an integrated communications specialist with a 15 year track record of success. We work together as a single multi-skilled team to craft the best and most effective solutions to your needs.We have brought together a 100-strong team with unparalleled experience of media, politics, the city, pressure groups, the digital world and business. With offices in London, Edinburgh and Washington DC, we are experts in providing award-winning brand, corporate, political, sustainability, financial and health communications advice.Our clients come from all aspects of business, the public and voluntary sectors. We’ve helped some of the world’s largest organisations. We’re equally committed to smaller causes Weniger anzeigen

• 

  Salterbaxter

  Feb 2011 - Aug 2011

  Head of Consultancy

  Head of Consultancy and team. Salterbaxter MSL, now part of Publicis Groupe, are management consultants specialising in strategy, sustainability and creative communications advisers to Europe’s largest and most exciting organisations. They help build long-term value for companies through five key disciplines: sustainability, digital communications, branding, corporate reporting and employee engagement.

• 

  RB

  Aug 2011 - Jan 2019

  Responsible for innovation across RB's health, hygiene and home categories, with a special focus on:1 - connected innovations - developing connected physical products & digital ecosystems2 - disruptive innovation - creating new market opportunities and brands for RB3 - consumer product insights - embedding the consumer into RB's product development process4 - sensorial - delighting our consumers with unique sensorial experiences5 - partnerships - finding the right partners at the right time Weniger anzeigen

  • VP - Health Innovation & Emerging Science

    Jan 2018 - Jan 2019

  • VP Innovation

    Sept 2016 - Jan 2017

  • VP / Category Group Director - Innovation & Sustainability

    Jan 2013 - Sept 2016

  • Director - Global Sustainability, Environment, Health and Safety

    Aug 2011 - Jan 2013
• 

  Bayer

  Jan 2020 - now

  This role brings together R&D and strategic marketing with the goal of building trusted brands to bring better selfcare to more people.Key responsibilities within marketing include global brand strategy, global consumer and market research, category marketing, marketing communications, digital, media, pricing and PR – with a special focus on megabrands, the largest and most iconic brands in Bayer portfolio, and marketing/commercial excellence and analytics across the organisation. Key responsibilities within R&D include worldwide end-to-end innovation and product development for all categories, brands & regions in addition to maintenance of the entire marketed products portfolio. Our talented team, working across 53 markets including five global science & innovation centres and six technical centres of excellence cover emerging science and early innovation, through product development to launch and post-launch improvements - with specialist expert teams in digital, design, packaging, formulation, RX-to-OTC Switch, open innovation, sustainability and product research.Additional enterprise responsibilities include leading the development of the global CH strategy with the consumer health leadership team, with identification of growth priorities and portfolio choices across all Bayer Consumer Health categories:•allergy (Claritin and AstePro, 2022 Rx-to-OTC Switch)•cough and cold (Afrin, Alka-Seltzer Plus, Tabcin, Asprin)•cardiovascular risk prevention (Bayer Aspirin)•dermatology (Bepanthen, Canesten, Lotrimin, Priorin)•vitamins, minerals and supplements (VMS) (One-A-Day, Supradyn, Berocca, Redoxon)•analgesics (Aleve, Aspirin, Midol, Flanax)•digestive health (Iberogast, Rennie, Miralax, Talcid) Weniger anzeigen Responsible for global R&D and innovation at Bayer Consumer Health, part of the Executive Committee and reporting to the CEO. Our talented team, working across 53 markets including five global science & innovation centres, cover emerging science and early innovation, through product development to launch and post-launch improvements - with specialist expert teams in digital, design, packaging, RX-to-OTC Switch, open innovation sustainability and product research.Chair, Innovation CommitteeChair, Technical Excellence CommitteeChair, Bayer Group R&D Executive Committee (consumer health, pharmaceuticals, crop science, corporate)Core, adjacent and transformational innovation (inc digital) for all Bayer Consumer Health categories:•allergy (Claritin and AstePro, 2022 Rx-to-OTC Switch)•cough and cold (Afrin, Alka-Seltzer Plus, Tabcin, Asprin)•cardiovascular risk prevention (Bayer Aspirin)•dermatology (Bepanthen, Canesten, Lotrimin, Priorin)•vitamins, minerals and supplements (VMS) (One-A-Day, Supradyn, Berocca, Redoxon)•analgesics (Aleve, Aspirin, Midol, Flanax)•digestive health (Iberogast, Rennie, Miralax, Talcid) Weniger anzeigen

  • Executive Board Member and Chief Marketing & Scientific Officer, Consumer Health

    Jan 2024 - now

  • Executive Board Member and Chief Scientific Officer, Head of R&D Consumer Health

    Jan 2020 - Jan 2024